Premarital vaccinations: 99% safe and protects against cancer
In a pioneering health initiative aimed at promoting family and community health, a health specialist at the Sayed Ali Al-Salman Center in Qatif Governorate recommended that women planning to marry receive premarital vaccinations. The specialist emphasized that these vaccines, specifically the human papillomavirus (HPV) and the MMR (measles, mumps, rubella) vaccine, have a high safety rate of up to 99% and play a crucial role in protecting women from serious types of cancer, as well as preventing health complications that may occur during pregnancy.
Medical advancements in premarital vaccination programs
Preventive healthcare programs have witnessed remarkable development over the decades. Historically, many countries, including Saudi Arabia, began implementing mandatory premarital medical screening programs to reduce the spread of genetic and infectious diseases. With continuous medical advancements, this has expanded beyond laboratory tests to include proactive preventive interventions such as premarital vaccinations. This development reflects a strategic shift in global and local health policies, with a focus on preventing viral diseases that can affect the health of both mother and fetus, representing a qualitative leap in the concept of building a healthy, disease-free family.
MMR vaccine: Protection for mother and fetus
Amal Al-Yousef, a nurse at the premarital health education clinic, explained that the clinic provides two essential vaccinations included in the mandatory premarital screenings. The first is the safe and effective MMR (measles, mumps, rubella) vaccine, a crucial preventative measure against measles, mumps, and rubella. This vaccine directly contributes to reducing health problems and birth defects that can affect fetuses if the mother is infected. It is administered in two doses, separated by the pregnancy, according to approved medical recommendations to ensure maximum effectiveness.
HPV vaccine: A protective shield against cancer
The specialist nurse discussed the second vaccine, the human papillomavirus (HPV) vaccine, describing it as a strategic preventative measure to reduce the spread of cervical cancer and genital warts. She noted that this vaccination reduces the risk of other types of cancer with an effectiveness exceeding 99 percent. This vaccine is administered to women in a maximum of three doses before the onset of sexual intercourse. To ensure the highest possible level of health protection for women, this campaign targets the age group between nine and forty-nine years old.
The strategic impact of strengthening community immunity
The commitment to receiving preventive vaccinations has far-reaching positive impacts. Locally, these initiatives help alleviate the financial and psychological burden on the healthcare system and on families by reducing the incidence of chronic and life-threatening diseases. Regionally and internationally, expanding access to the HPV vaccine aligns perfectly with the World Health Organization’s global strategy to accelerate the elimination of cervical cancer as a public health threat. Enabling women to access these vaccines improves national health indicators and enhances the quality of life for future generations.
Categories exempt from vaccination to ensure safety
In closing, Al-Yousef emphasized that these vaccines are available to all women planning to marry, with specific and precise medical exceptions to ensure the safety of recipients. These exceptions include women with severe allergies to the vaccine's components or those suffering from certain immune system disorders. Additionally, those undergoing medical treatments that may interact with the vaccine's active ingredients are also excluded, underscoring the importance of individual medical consultation before receiving any preventative treatment.
